SEPTEMBER 2014

Legal Expert Board

33

make it difficult for some firms who are not accustomed to working on multi- jurisdictional cross border transactions.

Fortunately, at Dentons, we have a global platform that enables our clients to get the highest quality legal counsel in more than 50 countries.

How do you feel it may progress in 2015; what legislative changes are on the horizon/do you see the need for?

Assuming interest rates remain low, and U.S. and key global economies don’t suffer significant set backs, I would expect continued high level of M&A activity in the U.S. Legislative changes may well depend on the outcome of U.S. mid-term elections. So-called “tax inversion” transactions have received a lot of press recently as well as attention from our government. These large deals, such as Pfizer’s pursuit of AstraZeneca, the

Medtronic/Covidien deal and Abbvie’s interest in Shire, have been high

profile and have received regulatory scrutiny.

Were this

year,

there many cross-border M&As or were they predominantly

domestic?

While the volume of U.S. deals remains predominantly domestic, there is a rapidly increasing amount of cross border M&A; particularly inbound acquisitions of U.S. companies.

What is the aim for your firm in 2015?

We continue to focus on our efforts to be the only truly polycentric, global law firm. We celebrate our multicultural nature and the diversity of lawyers and professionals as an organization with no headquarters and no dominant culture. We believe that gives us a competitive advantage in a marketplace where the purchasers of legal services are increasingly diverse and seeking diversity in their legal teams. LM

❝

Assuming interest rates remain low, and U.S. and key global economies don’t suffer

significant set backs, I would expect continued high level of M&A activity in the U.S.

www.lawyer-monthly.com

❝